Alfin Inc & lt ; AFN > said received regulatory letter Office Compliance U.S. Food Drug Administration asserting labelling certain advertising claim Glycel product `` new drug '' within meaning Federal Food , Drug Cosmetic Act approval obtained `` misbranded '' labelling .
The company said understands action part industry-wide investigation .
The company added reviewing matter counsel , intends respond take corrective action , necessary .
Reuter & # 3 ; 